Items where Author is "Brunner, P."

2023

Schilling, O. S. and Nagaosa, K. and Schilling, T. U. and Brennwald, M. S. and Sohrin, R. and Tomonaga, Y. and Kipfer, R. and Brunner, P. and Kato, K.. (2023) Revisiting Mt. Fuji's groundwater origins with helium, vanadium and eDNA tracers. Nature Water, 1. pp. 60-73.

2022

Schilling, O. S. and Partington, D. J. and Doherty, J. and Kipfer, R. and Hunkeler, D. and Brunner, P.. (2022) Buried paleo-channel detection with a groundwater model, tracer-based observations, and spatially varying, preferred anisotropy pilot point calibration. Geophysical Research Letters, 49 (14). e2022GL098944.

2014

Romer, A. and Seiler, D. and Marincek, N. and Brunner, P. and Koller, M. T. and Ng, Q. K. T. and Maecke, H. R. and Müller-Brand, J. and Rochlitz, C. and Briel, M. and Schindler, C. and Walter, M. A.. (2014) Somatostatin-based radiopeptide therapy with [(177)Lu-DOTA]-TOC versus [ (90)Y-DOTA]-TOC in neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, Vol. 41, H. 2. pp. 214-222.

2013

Marincek, N. and Jorg, A. C. and Brunner, P. and Schindler, C. and Koller, M. T. and Rochlitz, C. and Muller-Brand, J. and Maecke, H. R. and Briel, M. and Walter, M. A.. (2013) Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study. Journal of translational medicine, Vol. 11 , 17. p. 17.

2012

Villard, L. and Romer, A. and Marincek, N. and Brunner, P. and Koller, M. T. and Schindler, C. and Ng, Q. K. and Macke, H. R. and Muller-Brand, J. and Rochlitz, C. and Briel, M. and Walter, M. A.. (2012) Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 30, H. 10. pp. 1100-1106.

2011

Imhof, A. and Brunner, P. and Marincek, N. and Briel, M. and Schindler, C. and Rasch, H. and Macke, H. R. and Rochlitz, C. and Muller-Brand J., and Walter, M. A.. (2011) Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 29, H. 17. pp. 2416-2423.

2006

Brunner, P. and Sözer-Topcular, N. and Jockers, R. and Ravid, R. and Angeloni, D. and Fraschini, F. and Eckert, A. and Müller-Spahn, F. and Savaskan, E.. (2006) Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. European journal of histochemistry, Vol. 50, No. 4. pp. 311-316.